Asymptomatic Lambert-Eaton syndrome
Related Experiment Video
Updated: May 5, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
1Department of Neurosciences, California Pacific Medical Center, San Francisco, California, USA.
Introduction:
All descriptions of the Lambert-Eaton syndrome are based on symptomatic patients. We incidentally encountered electromyographic evidence of this syndrome in a patient being studied for another reason. The patient had controlled hypothyroidism and smoked for 9 pack-years but never had symptoms of weakness or had evidence of cancer.
Methods:
Detailed electrophysiological and serological evaluations were undertaken in this study.
Results:
Neuromuscular transmission tests were consistent with a presynaptic disorder. Autoantibodies specific for P/Q-type voltage-gated calcium channels (VGCC) were detected in the serum and persisted throughout 7 years of follow-up. Multiple IgG markers of thyrogastric autoimmunity also were detected.
Conclusions:
This demonstration of asymptomatic Lambert-Eaton syndrome persisting for 8 years provided novel insight into the natural history of the disorder. It is plausible that patients with a subclinical syndrome would have abrupt neuromuscular decompensation when challenged with medications that compromise the safety factor for synaptic transmission.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Myasthenia Gravis ll: Pathophysiology
Arboviral Encephalitis
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

